Terms ending in 2041
Every in-force patent on Institut Pasteur de Lille's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,926,664 | Methods and Pharmaceutical Compositions for Modulating Monocytopoiesis Inserm (Institut National de la Santé et de la Recherche Médicale), Institut Pasteur de Lille, Centre National de la Recherche Scientifique (CNRS) and Université de Lille In force · High confidence | Inserm (Institut National de la Santé et de la Recherche Médicale), Institut Pasteur de Lille, Centre National de la Recherche Scientifique (CNRS) and Université de Lille | In force | High confidence |
1 of 1 patent shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.